UBS Group AG - SOPHIA GENETICS SA ownership

SOPHIA GENETICS SA's ticker is and the CUSIP is H82027105. A total of 35 filers reported holding SOPHIA GENETICS SA in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SOPHIA GENETICS SA
ValueSharesWeighting
Q3 2023$27,282
-42.1%
10,720
+2.0%
0.00%
Q2 2023$47,085
-35.8%
10,510
-28.8%
0.00%
Q1 2023$73,327
+97.9%
14,754
-18.0%
0.00%
Q4 2022$37,047
-69.1%
17,984
-60.7%
0.00%
Q3 2022$120,000
-27.3%
45,725
-0.1%
0.00%
Q2 2022$165,000
+17.9%
45,758
+153.4%
0.00%
Q1 2022$140,000
-44.9%
18,058
+0.2%
0.00%
Q4 2021$254,000
+35.8%
18,014
+69.1%
0.00%
Q3 2021$187,00010,6560.00%
Other shareholders
SOPHIA GENETICS SA shareholders Q2 2022
NameSharesValueWeighting ↓
PFM Health Sciences, LP 2,014,024$15,568,0000.58%
GENERATION INVESTMENT MANAGEMENT LLP 6,789,560$52,483,0000.24%
PURA VIDA INVESTMENTS, LLC 829,930$6,415,0000.21%
BANK PICTET & CIE (ASIA) LTD 64,420$498,0000.14%
BANQUE PICTET & CIE SA 2,096,420$16,205,0000.12%
Moloney Securities Asset Management, LLC 71,450$552,0000.11%
GENERAL ELECTRIC CO 1,111,111$8,588,8880.09%
Bank Pictet & Cie (Europe) AG 227,600$1,759,0000.07%
RTW INVESTMENTS, LP 226,589$1,752,0000.04%
DRIEHAUS CAPITAL MANAGEMENT LLC 287,406$2,222,0000.03%
View complete list of SOPHIA GENETICS SA shareholders